Glauco da Costa Alvarez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Glauco da Costa Alvarez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aline Calcing
Univ Franciscana UFN, Ruas Siva Jardim 1175,Conjunto 3, BR-97010491 Santa Maria, RS, Brazil
1 shared publication - Ana Cristina DE Assunção Machado
Univ Fed Santa Maria UFSM, Santa Maria, RS, Brazil
1 shared publication Ana Cristina Machado
Federal University of Santa Maria
1 shared publication- Cristina Machado Bragança de Moraes
Univ Franciscana UFN, Ruas Siva Jardim 1175,Conjunto 3, BR-97010491 Santa Maria, RS, Brazil
1 shared publication Deise Silva de Moura
Pontificia Univ Catolica Rio Grande do Sul PUCRS, Porto Alegre, RS, Brazil
1 shared publicationDener T. Girardon
Federal University of Santa Maria
1 shared publication
Latest Publications
- Open Access
- 5 August 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 81, 104211
Analysis of hepatic markers and lipid profile of patients submitted to gastric by-pass after 2 years – Cohort retrospective
Ospective cohort and descriptive study, performed by consulting the database of an Obesity and Digestive Surgery Clinic in the city of Santa Maria – (Rio Grande do Sul, Brazil). The study included 351 patients (284 women, 67 men), aged at least 18 years, who underwent bariatric surgery from March 2014 to March 2016. The following data were obtained from the patients’ medical records: Weight, height, age, sex, associated morbidities, biochemical parameters. The data were described by mean and standard deviation, median and interquartile range, count, and percentages. Results: The results showed a significant reduction in excess loss, triglycerides (TG) and low-density lipoprotein (LDLc) cholesterol variables in the prospective period, while high-density lipoprotein (HDLc) cholesterol levels increased, thus minimizing the hepatic changes. There was a reduction in LDLc and an increase in HDLc at 24 months in both groups 1 and 2. Between 6 and 12 months, total cholesterol (TC) increased in group 2, however, in the period between 12 and 18 months, only G1 had triglycerides reduced. In the period of 18 and 24 months, there was a significant reduction in blood glucose in group 1. The variables AST and ALT were within the normal range, without significance. However, 84.3% of patients had grade I hepatic steatosis. Conclusion: Bariatric surgery is effective in reducing the %EWL, modifying the lipid profile and liver markers up to 24 months after the bypass, reducing associated comorbidities. More research is needed to clarify the impact of %PEP on liver indicators and lipid profile two years after SB. HIGHLIGHTS In the study, the prevalence of obesity was higher in females (80.9%).The present study showed an important reduction in the percentage of excess weight loss (%EWL), reduction of liver markers and improvement in the lipid profile in the 24 months after the surgical intervention.BS can guarantee an improvement in quality of life, while reducing CVR, dyslipidemia and liver changes.The effectiveness of BS is an important factor in weight loss, with improvement in anthropometric and biochemical parameters, and reduction of morbidities associated with obesity....
- 5 August 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 81, 104211
Open AccessAnalysis of hepatic markers and lipid profile of patients submitted to gastric by-pass after 2 years – Cohort retrospective
Ospective cohort and descriptive study, performed by consulting the database of an Obesity and Digestive Surgery Clinic in the city of Santa Maria – (Rio Grande do Sul, Brazil). The study included 351 patients (284 women, 67 men), aged at least 18 years, who underwent bariatric surgery from March 2014 to March 2016. The following data were obtained from the patients’ medical records: Weight, height, age, sex, associated morbidities, biochemical parameters. The data were described by mean and standard deviation, median and interquartile range, count, and percentages. Results: The results showed a significant reduction in excess loss, triglycerides (TG) and low-density lipoprotein (LDLc) cholesterol variables in the prospective period, while high-density lipoprotein (HDLc) cholesterol levels increased, thus minimizing the hepatic changes. There was a reduction in LDLc and an increase in HDLc at 24 months in both groups 1 and 2. Between 6 and 12 months, total cholesterol (TC) increased in group 2, however, in the period between 12 and 18 months, only G1 had triglycerides reduced. In the period of 18 and 24 months, there was a significant reduction in blood glucose in group 1. The variables AST and ALT were within the normal range, without significance. However, 84.3% of patients had grade I hepatic steatosis. Conclusion: Bariatric surgery is effective in reducing the %EWL, modifying the lipid profile and liver markers up to 24 months after the bypass, reducing associated comorbidities. More research is needed to clarify the impact of %PEP on liver indicators and lipid profile two years after SB. HIGHLIGHTS In the study, the prevalence of obesity was higher in females (80.9%).The present study showed an important reduction in the percentage of excess weight loss (%EWL), reduction of liver markers and improvement in the lipid profile in the 24 months after the surgical intervention.BS can guarantee an improvement in quality of life, while reducing CVR, dyslipidemia and liver changes.The effectiveness of BS is an important factor in weight loss, with improvement in anthropometric and biochemical parameters, and reduction of morbidities associated with obesity....
- 1 April 2007
- Published by Springer Nature in Obesity Surgery
- Vol. 17 (4) , 550-552
Laparoscopic Spleen-Preserving Distal Pancreatectomy as Treatment for Nesidioblastosis after Gastric Bypass Surgery
Nesidioblastosis is characterized by hyperfunction of pancreatic islets caused by hypertrophic beta cells. Postprandial symptoms of hypoglycemia are the clinical presentation of the disease. A female patient with diabetes mellitus who underwent a Roux-en-Y gastric bypass began to present postprandial symptoms of hypoglycemia. There was no radiologic (MRI) evidence of insulinoma. Selective arterial calcium-stimulation test identified hyperfunction only in the splenic artery. Laparoscopic spleen-preserving distal pancreatectomy was performed.The patient has been entirely free of any postprandial symptoms for 10 months after the partial pancreatectomy.
- 1 April 2007
- Published by Springer Nature in Obesity Surgery
- Vol. 17 (4) , 550-552
Laparoscopic Spleen-Preserving Distal Pancreatectomy as Treatment for Nesidioblastosis after Gastric Bypass Surgery
Nesidioblastosis is characterized by hyperfunction of pancreatic islets caused by hypertrophic beta cells. Postprandial symptoms of hypoglycemia are the clinical presentation of the disease. A female patient with diabetes mellitus who underwent a Roux-en-Y gastric bypass began to present postprandial symptoms of hypoglycemia. There was no radiologic (MRI) evidence of insulinoma. Selective arterial calcium-stimulation test identified hyperfunction only in the splenic artery. Laparoscopic spleen-preserving distal pancreatectomy was performed.The patient has been entirely free of any postprandial symptoms for 10 months after the partial pancreatectomy.